Zobrazeno 1 - 10
of 350
pro vyhledávání: '"Sreeram V Ramagopalan"'
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 10 (2024)
Externí odkaz:
https://doaj.org/article/0e443eabfc8c467aa15cfb0a3f5ac51b
Autor:
Sreeram V Ramagopalan, Manuel Gomes, Isabelle Durand-Zaleski, Bill Malcolm, Jose Diaz, Grace Mitchell, Jonathan Pearson-Stuttard, Louis P Garrison Jr
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/f24885864e734f09994c94a4839754e2
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/ac535fd87a54473fab495d3a02b33586
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 8 (2024)
In this update, we discuss recent US FDA guidance offering more specific guidelines on appropriate study design and analysis to support causal inference for non-interventional studies and the launch of the European Medicines Agency (EMA) and the Head
Externí odkaz:
https://doaj.org/article/befa342d72734a648f96da9e4e300dce
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 7 (2024)
Externí odkaz:
https://doaj.org/article/1623ca576d264796a4957219e2fcc879
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/5f14e94285f84df4a7380f20621ea5fb
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 6, Iss 13 (2024)
In this latest update, we look at recent developments in market access including the pricing agreement of Libmeldy by the Beneluxa Initiative, the financial impact of managed entry agreements in Italy and the restructuring of Agenzia Italiana del Far
Externí odkaz:
https://doaj.org/article/d3c9f59e8747475a96b2efec8b3342b7
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/2cebde54ef9340faa8196724476a45b3
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 3 (2024)
In this latest update, we explore some of the key updates in market access over recent months including the UK’s voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in th
Externí odkaz:
https://doaj.org/article/afc97ac51a8b48b398a9a27ebcce3c5c
Autor:
Benjamin D Bray, Sreeram V Ramagopalan
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 1 (2024)
In this latest update we highlight: a publication from the US FDA regarding the definitions of real-world data (RWD) and real-world evidence (RWE); a publication from academic researchers on a demonstration project for target trial emulation; a publi
Externí odkaz:
https://doaj.org/article/ee89c10f706943868a04b863eaf4fa34